From prediction to experimental validation: desmoglein 2 is a functionally relevant substrate of matriptase in epithelial cells and their reciprocal relationship is important for cell adhesion - PubMed (original) (raw)
. 2012 Oct 1;447(1):61-70.
doi: 10.1042/BJ20111432.
Affiliations
- PMID: 22783993
- DOI: 10.1042/BJ20111432
From prediction to experimental validation: desmoglein 2 is a functionally relevant substrate of matriptase in epithelial cells and their reciprocal relationship is important for cell adhesion
Vinita Wadhawan et al. Biochem J. 2012.
Abstract
Accurate identification of substrates of a protease is critical in defining its physiological functions. We previously predicted that Dsg-2 (desmoglein-2), a desmosomal protein, is a candidate substrate of the transmembrane serine protease matriptase. The present study is an experimental validation of this prediction. As demanded by our published method PNSAS [Prediction of Natural Substrates from Artificial Substrate of Proteases; Venkatraman, Balakrishnan, Rao, Hooda and Pol (2009) PLoS ONE 4, e5700], this enzyme-substrate pair shares a common subcellular distribution and the predicted cleavage site is accessible to the protease. Matriptase knock-down cells showed enhanced immunoreactive Dsg-2 at the cell surface and formed larger cell clusters. When matriptase was mobilized from intracellular storage deposits to the cell surface there was a decrease in the band intensity of Dsg-2 in the plasma membrane fractions with a concomitant accumulation of a cleaved product in the conditioned medium. The exogenous addition of pure active recombinant matriptase decreased the surface levels of immunoreactive Dsg-2, whereas the levels of CD44 and E-cadherin were unaltered. Dsg-2 with a mutation at the predicted cleavage site is resistant to cleavage by matriptase. Thus Dsg-2 seems to be a functionally relevant physiological substrate of matriptase. Since breakdown of cell-cell contact is the first major event in invasion, this reciprocal relationship is likely to have a profound role in cancers of epithelial origin. Our algorithm has the potential to become an integral tool for discovering new protease-substrate pairs.
Similar articles
- Proteolytic processing of the serine protease matriptase-2: identification of the cleavage sites required for its autocatalytic release from the cell surface.
Stirnberg M, Maurer E, Horstmeyer A, Kolp S, Frank S, Bald T, Arenz K, Janzer A, Prager K, Wunderlich P, Walter J, Gütschow M. Stirnberg M, et al. Biochem J. 2010 Aug 15;430(1):87-95. doi: 10.1042/BJ20091565. Biochem J. 2010. PMID: 20518742 - The influence of matriptase-2 on prostate cancer in vitro: a possible role for β-catenin.
Webb SL, Sanders AJ, Mason MD, Jiang WG. Webb SL, et al. Oncol Rep. 2012 Oct;28(4):1491-7. doi: 10.3892/or.2012.1945. Epub 2012 Aug 2. Oncol Rep. 2012. PMID: 22858929 - Activation of a membrane-bound serine protease matriptase on the cell surface.
Miyake Y, Yasumoto M, Tsuzuki S, Fushiki T, Inouye K. Miyake Y, et al. J Biochem. 2009 Aug;146(2):273-82. doi: 10.1093/jb/mvp066. Epub 2009 Apr 26. J Biochem. 2009. PMID: 19398443 - The type II transmembrane serine protease, matriptase-2: Possible links to cancer?
Sanders AJ, Webb SL, Parr C, Mason MD, Jiang WG. Sanders AJ, et al. Anticancer Agents Med Chem. 2010 Jan;10(1):64-9. doi: 10.2174/1871520611009010064. Anticancer Agents Med Chem. 2010. PMID: 20015002 Review. - Matriptase-2, a regulatory protease of iron homeostasis: possible substrates, cleavage sites and inhibitors.
Stirnberg M, Gütschow M. Stirnberg M, et al. Curr Pharm Des. 2013;19(6):1052-61. doi: 10.2174/1381612811319060007. Curr Pharm Des. 2013. PMID: 23016685 Review.
Cited by
- The polybasic insert, the RBD of the SARS-CoV-2 spike protein, and the feline coronavirus - evolved or yet to evolve.
Budhraja A, Pandey S, Kannan S, Verma CS, Venkatraman P. Budhraja A, et al. Biochem Biophys Rep. 2021 Mar;25:100907. doi: 10.1016/j.bbrep.2021.100907. Epub 2021 Jan 13. Biochem Biophys Rep. 2021. PMID: 33521335 Free PMC article. - Desmoglein 2 is less important than desmoglein 3 for keratinocyte cohesion.
Hartlieb E, Kempf B, Partilla M, Vigh B, Spindler V, Waschke J. Hartlieb E, et al. PLoS One. 2013;8(1):e53739. doi: 10.1371/journal.pone.0053739. Epub 2013 Jan 11. PLoS One. 2013. PMID: 23326495 Free PMC article. - Kempopeptin C, a Novel Marine-Derived Serine Protease Inhibitor Targeting Invasive Breast Cancer.
Al-Awadhi FH, Salvador LA, Law BK, Paul VJ, Luesch H. Al-Awadhi FH, et al. Mar Drugs. 2017 Sep 16;15(9):290. doi: 10.3390/md15090290. Mar Drugs. 2017. PMID: 28926939 Free PMC article. - Desmoglein-2 as a cancer modulator: friend or foe?
Myo Min KK, Ffrench CB, McClure BJ, Ortiz M, Dorward EL, Samuel MS, Ebert LM, Mahoney MG, Bonder CS. Myo Min KK, et al. Front Oncol. 2023 Dec 22;13:1327478. doi: 10.3389/fonc.2023.1327478. eCollection 2023. Front Oncol. 2023. PMID: 38188287 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous